Transcriptional regulation of MDR genes

Cytotechnology

Volumn 27, Issue 1-3, 1998, Pages 257-269

  Scotto, Kathleen W ^a   Egan, David A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

MDR1; Multidrug resistance; P glycoprotein; Transcriptional regulation

Indexed keywords

ANTIINFECTIVE AGENT; CANCER CHEMOTHERAPY; GLYCOPROTEIN P; MULTIDRUG RESISTANCE; TRANSCRIPTION REGULATION; TUMOR CELL;

EID: 0032427211     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-2374-9_17     Document Type: Article

References (97)

1. Abolhoda A, Wilson AE, Ross H, Scotto KW and Burt M (1997) Transcriptional upregulation of the MDR1 gene expression in human metastatic sarcoma following transient in vivo exposure to doxorubicin. Proc Amer Assoc Cane Res 38: 251.
2. Akira S and Kishimoto T (1992) IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127: 25-50.
3. Arceci RJ, Baas F, Raponi R, Horwitz SB, Housman D and Croop JM (1990) Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Molecular Reproduction and Development 25: 101-109.
4. Asakuno K, Kohno K, Uchiumi T, Kubo T, Sato S, Isono M and Kuwano M (1994) Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D. Biochem and Biophys Res Comm 199(3): 1428-1435.
5. Banerjee D, Ercikan-Abali E, Waltham M, Schnieders B, Hochhauser D, Li WW, Fan F, Gorlick R, Goker E and Bertino JR (1995) Molecular mechanisms of resistance to antifolates, a review. Acta Biochim Pol 42(4): 457-464.
6. Bargou R, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara M, Winzer K, Dietel M, Dorken B and Royer H (1997) Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3(4): 447-450.
7. Bates SE, Mickley LA, Chen YN, Richert N, Rudick J, Biedler JL and Fojo AT (1989) Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation Mol Cell Biol 9(10): 4337-4344.
8. Bhushan A, Abramson R, Chiu JF and Tritton TR (1994) Expression of c-fos in human and murine multidrug-resistant cells. Mol Pharmacol 42: 69-74.
9. Borst P and Schinkel AH (1997) Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet 13(6): 217-222.
10. Brown P and Silverman J (1996) Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1. Nucleic Acids Res 24(16): 3235-3241.
11. Burt RK, Garfield S, Johnson K and Thorgeirsson SS (1998) Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenisis 9(12): 2329-2332.
12. Chaudhary PM and Roninson IB (1993) Induction of multidrug resistance in human cells by transient exposure to chemotherapeutic drugs. J Natl Cancer Inst 85: 632-639.
13. Chieli E, Santoni-Rugiu E, Cervelli F, Sabbatini A, Petrini M, Romiti N, Paolicchi A and Tongiani R (1994) Differential modulation of P-glycoprotein expression by dexamethasone and 3-methylcholanthrene in rat hepatocyte primary cultures. Carcinogenesis 15(2): 335-341.
14. Chin, K, Chauhan S, Pastan I and Gettesman M (1990) Regulation mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth and Diff 1: 361-365.
15. Chin KV, Tanaka S, Darlington G, Pastan I and Gottesman MM (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 265: 221-226.
16. Chin KV, Ueda K, Pastan I and Gottesman MM (1992) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255: 459-462.
17. Combates NJ, Rzepka RW, Chen YN and Cohen D (1994) NF-IL6 a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J Biol Chem 269: 29715-9.
18. Cornwell MM (1990) The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription. Cell Growth Differ 1: 607-615.
19. Cornwell MM and Smith DE (1993a) SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J Biol Chem 268: 19505-11.
20. Cornwell MM and Smith DE (1993b) A signal transduction pathway for activation of the MDR-1 promoter involves the protooncogene c-raf kinase. J Biol Chem 268: 15347-15350.
21. Cvijic M and Chin K (1997) Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants. Cell Growth and Diff 8: 1243-1247.
22. Egan DA and Scotto KW (1996) Glucocorticoids repress transcription of the hamster Class I P-glycoprotein promoter through an activator occlusion mechanism. Proc Amer Assoc Cancer Res 37: 324.
23. Fairchild CR and Cowan KH (1991) Keynote address: multidrug resistance: a pleiotropic response to cytotoxic drugs. Int J Radiat Oncol Biol Phys 10(2): 361-367.
24. Fardel O, Lecureur V, Corlu A and Guillouzo A (1996) P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment. Biochem Pharmacol 51(11): 1427-1436.
25. Fardel O, Lecureur V and Guillouzo A (1996) The P-glycoprotein multidrug transporter. Gen Pharmacol 27(8): 1283-1291.
26. Ferrandis E and Bernard J (1994) Retinoic acid and forskolin activate the human MDR1 gene promoter in differentiated neuroblasts. Prog Clin Biol Res 385: 103-110.
27. Gant TW, Silverman JA, Bisgaard HC, Burt RK, Marino PA and Thorgeirsson SS (1991) Regulation of 2-acetylaminofluorene-and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P45OIA gene family expression in primary hepatocyte cultures and rat liver. Mol Carcinog 4(6): 499-509.
28. Gant TW, Schrenk D, Silverman JA and Thorgeirsson SS (1994) Requirement for metabolic activation of acetylaminofluorene to induce multidrug gene expression. Environ Health Perspect 102(6): 209-212.
29. Gekeler V, Frese G, Diddens H and Probst H (1988) Expression of a P-glycoprotein gene is inducible in a multidrug-resistant human leukemia cell line. Biochem Biophys Res Commun 155(2): 754-760.
30. Germann U, Schoenlein P, Zimonjic D, Popescu N, Pastan I and Gettesman M (1994) Putative 'MDR Enhancer' is located on human chromosome 20 and not linked to the MDR1 gene on chromosone 7. Genes, Chromosomes and Cancer 10: 267-274.
31. Goldsmith M, Gudas J, Schneider E and Cowan K (1995) Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. J Biol Chem 270(4): 1894-1898.
32. Goldsmith ME, Madden MJ, Morrow CS and KH Cowan (1993) A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J Biol Chem 268: 5856-60.
33. Hampsey M (1998) Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol Mol Biol Rev 62(2): 465-503.
34. Hill, B, Brown P, Preisegger K and Silverman J (1996) Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro. Carcinogenesis 17(3): 451-457.
35. Hu, XF, Slater A, Wall DM, Kantharidis P, Parkin JD, Cowman A and Zalcberg JR (1995) Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant line. British J Cancer 71: 931-936.
36. Ikeguchi M, Teeter LD, Eckersberg T, Ganapathi R and Kuo MT (1991) Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. DNA and Cell Biology 10(9): 639-49.
37. Ince TA and Scotto KW (1995a) Differential utilization of multiple transcription start points accompanies the overexpression of the P-glycoprotein-encoded gene in Chinese hamster lung cells. Gene 156: 287-290.
38. Ince TA and Scotto KW (1995b) A conserved downstream element defines a new class of RNA polymerase II promoters. J Biol Chem 270: 30249-30252.
39. Ince TA and Scotto KW (1996) Stable transfection of the P-glycoprotein promoter reproduces the endogenous overexpression phenotype: the role of MED-1 Cancer Res 56: 2021-2024.
40. Javahery R, Khachi A, Lo K, Zenzie-Gregory B and Smale ST (1994) DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol 14(1): 116-127.
41. Jin S and Scotto KW (1998) Transcriptional regulation of the MDR1 gene by histone acetyltransferase/deacetylase is mediated by NFY. Mol Cell Biol 18: 4377-4384.
42. Karin M, Liu Z and Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9(2): 240-246.
43. Kim SH, Park JI, Chung BS, Kang CD and Hidaka H (1993) Inhibition of MDR1 gene expression by H-87, a selective inhibitor of cAMP-dependent protein kinase. Cancer Letters 74: 37-41.
44. Kim SH, Hur WY, Kang CD, Lim YS, Kim DW and Chung BS (1997) Involvement of heat shock factor in regulating transcriptional activation of MDR1 gene in multidrug-resistant cells. Cancer Lett 115(1): 9-14.
45. Kim R and Beck WT (1994) Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Cancer Res 54(18): 4958-4966.
46. Kioka N, Yamano Y Komano T and Ueda K (1992) Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). Febs 301(1): 37-40.
47. Kohno K, Sato S, Uchiumi T, Takano H, Kato S and Kuwano M (1990) Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J Biol Chem 265(32): 19690-19696.
48. Kohno K, Sato S, Takano H, Matsuo K and Kuwano M (1989) The direct activation of human multidrug resistance gene (MDR1). Biochem and Biophys Res Commun 165(3): 1415-1421.
49. Lania L, Majello B and De Luca P (1997) Transcriptional regulation by the Sp family proteins. Int J Biochem Cell Biol 29(12): 1313-1323.
50. Latchman DS (1997) Transcription factors: an overview. Int J Biochem Cell Biol 29(12): 1305-1312.
51. Lecureur B, Guillouzo A and Fardel O (1996) Differential regulation of mdr genes in response to 2-acetylaminofluorene treatment in cultured rat and human hepatocytes. Carcinogenesis 17(5): 1157-1160.
52. Lee CH, Bradley G and Ling V (1994) Expression of P-glycoprotein in normal and malignant rat liver cells. Cold Spring Harbor Symposia on Quantitative Biology 59: 607-15.
53. Li Z, Zhu Y and Lit X (1997) Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line Kb v200. Cancer Letters 119: 177-184.
54. Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40: S3-S8.
55. Madden MJ, Morrow CS, Nakagawa M, Goldsmith M, Fairchild CR and Cowan KH (1993) Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J Biol Chem 268(11): 8290-8297.
56. Mallick S and Horwitz SB (1997) Transcriptional regulation of the murine multidrug resistance gene mdr1b by progesterone occurs via an indirect mechanism. DNA Cell Biol 16: 807-818.
57. Marino PA, Gottesman MM and Pastan I (1990) Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth and Differentiation 1(2): 57-62.
58. McCoy C, Smith DE and Cornwell MM (1995) TPA activation of the MDR1 promoter is mediated by EGR1. Mol Cell Biol 15: 6100-6108.
59. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N and Fojo A (1989) Modulation of the expression of a multidrug-resistance gene (mdr-1/P-glycoprotein) by differentiation agents. J Biol Chem 264: 18031-18040.
60. Miltenberger RJ, Farnham PJ, Smith DE, Stommel JM and Cornwell MM (1995) v-Raf activates transcription of growth-responsive promoters via GC-rich sequences that bind the transcription factor Sp1. Cell Growth Differ 6(5): 549-556.
61. Miyazaki M, Kohno K, Uchiumi T, Tanimura H, Matsuo K, Nasu M and Kuwano M (1992) Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem and Biophys Res Commun 187: 677-684.
62. Morrow CS, Nakagawa M, Goldsmith ME, Madden MJ and Cowan KH (1994) Reversible transcriptional activation of MDR1 by sodium butyrate treatment of human colon cancer cells. J Biol Chem 269: 10739-10746.
63. Nakatsukasa H, Silverman JA, Gant TW, Evarts RP and Thorgeirsson SS (1993) Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology 18: 1202-1207.
64. Nguyen KT, Liu B, Ueda K, Gottesman MM, Pastan I and Chim KV (1994) Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants. Oncol Res 6(2): 71-77.
65. Ogura M, Takatori T and Tsuruo T (1992) Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene. Nucleic Acids Res 20: 5811-5817.
66. Ohga T, Uchium T, Makino Y, Koike K, Wada M, Kuwano M and Kohno K (1998) Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem 273: 5997-6000.
67. Orphanides G, Lagrange T and Reinberg D (1996) The general transcription factors of RNA polymerase II. Genes Dev 10(21): 2657-2683.
68. Osborne MT and Chambers TC (1996) Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs. J Biol Chem 271(48): 30950-30955.
69. Pelech SL and Charest DL (1995) MAP kinase-dependent pathways in cell cycle control. Prog Cell Cycle Res 1: 33-52.
70. Piekarz RL Cohen D and Horwitz SB (1993) Progesterone regulates the murine multidrug resistance mdr1b gene. J of Biol Chem 268(11): 7613-6.
71. Redfern CP, Lovat PE, Malcolm AJ and Pearson AD (1995) Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur J Cancer 31 A(4): 496-494.
72. Rohlff C and Glazer RI (1995) Regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cell Signal 7(5): 431-443.
73. Scala S, Budillon A, Zhan Z, Cho-chumg Y, Jetterson J, Tsodos M and Bates S (1995) Downregulation of mdr-1 expression by 8-Cl cAMP in multidrug resistant MCF-7 human breast cancer cells. J Clinic Invest 96(2): 1026-1034.
74. Schuetz JD, Strom SC, Schuetz EG (1995) Induction of P-glycoprotein mRNA by protein synthesis inhibition is not controlled by a transcriptional repressor protein in rat and human liver cells. J Cell Physiol 165: 261-272.
75. Scheutz JD, Silverman JA, Thottassery JV, Furuya KN and EG Scheutz (1995) Divergent regulation of the class II p-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids. Cell Growth and Differ 7: 1321-32.
76. Song, R, Ikeguchi M, Zhou Ge and Kuo MT (1995) Identification and characterization of a hepatoma cell-specific enhancer in the mouse multidrug resistance mdr1b promoter. J Biol Chem 270: 25468-25474.
77. Scotto KW, Biedler J and Melera P (1986) Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 232(4751): 751-755.
78. Schrenk D, Gant TW, Michalke A, Orzechowski A, Silverman JA, Battula N and Thorgeirsson SS (1994) Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Carcinogenesis 15(11): 2541-2546.
79. Schuetz E, Beck W and Schuetz J (1996) Modulators and sub-strates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49(2): 311-318.
80. Shustik C, Dalton W and Gros P (1995) P-glycoprotein-mediated multidrug resistance in tumor cells: Biochemistry, clinical relevance and modulation. Molec Aspects Med 16: 1-78.
81. Smale ST (1997) Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim Biophys Acta 1351(1-2): 73-88.
82. Strauss BE, Shivakumar C, Deb S, Dev S and Haas M (1995) The MDR1 downstream promoter contains sequence-specific binding sites for wild-type p53. Biochem Biophys Res Commun 217(3): 825-831.
83. Struhl K (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12(5): 599-606.
84. Sundseth R, MacDonald G and King AC (1997) DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter. Mol Pharmacol 51(6): 963-971.
85. Takatori T, Ogura M and Tsuruo T (1993) Purification and characterization of NF-R2 that regulates the expression of the human multidrug resistance (MDR1) gene. J Cancer Res 28: 298-303.
86. Teeter LD, Eckersberg T, Tsai Y and MT Kuo (1991a) Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ 29: 429-37.
87. Teeter, LD, Petersen DD, Nebert DW and Kuo MT (1991b) Murine mdr-1, mdr-2, and mdr-3 gene expression: no coinduction with the Cypla-1 and Nmo-1 genes in liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin. DNA Cell Biol 10(6): 433-441.
88. Thottassery JV, Zambetti GP, Arimori K, Schuetz EG and Schuetz JD (1997) p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Acad Sci 94(20): 11037-11042.
89. Uchiumi T, Kohno K, Tanimura H, Matsuo K, Sato S, Uchida Y and Kuwano M (1993) Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ 4: 147-157.
90. Uchiumi T, Kohno K, Tanimura H, Matsuo K, Sato S, Uchida Y and Kuwano M (1993) Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth and Diff 4: 147-157.
91. Ueda K, Pastan I and Gottesman MM (1987) Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene J Biol Chem 262: 17432-17436.
92. Van Groenigen M, Valentijn L and Baas F (1993) Identification of a functional initiator sequence in the human MDR1 promoter. Biochim Biophys Acta 11272(1-2): 138-146.
93. Yu L, Wu Q, Yang C-PH and Horwitz SB (1995) Coordination of transcription factors, NF-Y and C/EBPβ in the regulation of the mdr1b promoter. Cell, Growth and Diff 6: 1505-1512.
94. Zastawny RL, Salvino R, Chen J, Benchimol S and Ling V (1993) The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. Oncogene 8(6): 1529-1535.
95. Zhao J, Ikeguchi M, Eckersberg T and Kuo M (1993) Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endo 133(2): 521-528.
96. Zhou G, Song R and Kuo MT (1996) A novel cis-acting element is involved in the promoter activity of the rat mdr1b gene. Cell Growth Differ 7(10): 1369-1381.
97. Zhou G and Kuo MT (1997) NF-KB-mediated induction of MDR1b expression by insulin in rat hepatoma cells. J Biol Chem 272: 15174-15183.